@FierceBiotech: In our latest report, we feature the top women in the biotech industry. Report | Follow @FierceBiotech
@JohnCFierce: Sanofi might want to reevaluate its cancer strategy about now. Iniparib and fedratinib both written off in '13. More | Follow @JohnCFierce
@DamianFierce: Pro-23andMe petition aims to protect "potentially life-saving diagnostic kits," thereby making the FDA's case. Petition | Follow @DamianFierce
@EmilyMFierce: Harvard study: 30% of all medical tests are probably unnecessary. More | Follow @EmilyMFierce
> Germany's Merck KGaA says it is hunting up new drug deals and buyouts to help expand its U.S. drugs business. Story
> Denmark's Genmab has earned an $8 million milestone from Johnson & Johnson ($JNJ) for the advancement of their cancer drug daratumumab. Story
@FierceMedDev: Becton Dickinson boost its quarterly dividend. Item | Follow @FierceMedDev
@MarkHFierce: J&J's $2.5B hip implant settlement offer is already beginning to generate some flack from patients. Story via NYT | Follow @MarkHFierce
> Hospira faces another pump recall over deadly risk. Story
> Patient anger could scuttle J&J's $2.5B hip settlement. Article
> Smith & Nephew's M&A blitz rolls on with Brazilian buy. News
> Dutch VC firm readies $200M fund with an eye on device and Dx investments. More
Pharma News
@FiercePharma: Monday's top story: Who leaked the scary Copaxone numbers? Teva intends to find out. Story | Follow @FiercePharma
@EricPFierce: Any who thinks women aren't controlling the destiny of biopharma would be wrong. Women in Biotech 2013 Report | Follow @EricPFierce
@CarlyHFierce: FDA withdraws restrictions on GSK diabetes drug Avandia - too little, too late? | Follow @CarlyHFierce
> Mylan, Biocon ready to roll out Herceptin biosimilar in India. Story
> FDA withdraws restrictions on GSK's Avandia. News
> Bayer bids $2.4B for Xofigo partner Algeta in drive for cancer growth. More
Pharma Manufacturing News
> JLL expects to buy more CMOs. Story
> Glaxo piles onto API expansion in Scotland. More
> PL Developments, Aaron combine expertise in OTC manufacturing. Article
> Ranbaxy ready to bail on vaccine manufacturing. More
> Bafna draws buyout interest for its European-approved manufacturing. News
Biotech Research News
> Eli Lilly, Project A.L.S. forge preclinical drug discovery pact. News
> Biota halts preclinical antibiotics program as antimicrobial resistance grows. Report
> New targets for Parkinson's revealed in gene network. Story
> Antibiotics may weaken body's response to cancer therapies. Article
> New York Stem Cell Foundation, NIH partner to study rare diseases. Story